Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
Travel and Tropical Medicine
Under what circumstances do you recommend the chikungunya vaccine for travelers to areas without a current outbreak but with elevated risk, especially for extended stays?
Related Questions
What specific clinical signs or epidemiological indicators do you prioritize for early identification of Bartonella quintana infection?
Do you routinely recommend doxycycline for pregnant individuals with rickettsial diseases despite the historical concern for side effects in pregnancy?
How do you approach vaccination, particularly the use of live vaccines such as yellow fever, in a patient with rheumatoid arthritis receiving a TNF inhibitor who is planning travel to Africa?
How do you make decisions about decolonization for a chronic asymptomatic MRSA carrier?
How would you approach the management of a suspected macrolide-resistant pertussis outbreak in a hospital or community setting?
Do you recommend treating Candida albicans on urine culture from an indwelling catheter in a patient with septic shock?
How do you determine total duration of treatment for complicated GBS meningitis?
Do you recommend surveillance lumbar punctures for patients with Mollaret's meningitis after diagnosis or in between clinical episodes?
Do you always stop dexamethasone at discharge for patients admitted with COVID requiring respiratory support (as done in the RECOVERY trial), or are there situations in which you will prescribe it to complete a 10-day course?
Do you favor a certain NRTI to pair with dolutegravir and lamivudine in persons with HIV to minimize the risk of resistance to dolutegravir?
